Research from both the Gabrilovich lab and Ostrand-Rosenberg lab has identified S100A8 and S100A9 as factors which contribute to differentiating immature myeloid cells to become MDSCs and the accumulation of these cells during cancer progression (8, 9). Here, S100A8 is linked to cancer.